Lipe & Dalton Reduces Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Lipe & Dalton lessened its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 8.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,096 shares of the medical device company’s stock after selling 1,100 shares during the period. Lipe & Dalton’s holdings in Cooper Companies were worth $1,020,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of the stock. City Holding Co. purchased a new position in Cooper Companies during the first quarter worth about $34,000. New Age Alpha Advisors LLC purchased a new position in Cooper Companies during the fourth quarter worth about $38,000. Covestor Ltd raised its holdings in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock worth $42,000 after purchasing an additional 120 shares in the last quarter. Larson Financial Group LLC raised its holdings in Cooper Companies by 1,071.0% during the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company’s stock worth $61,000 after purchasing an additional 664 shares in the last quarter. Finally, HM Payson & Co. raised its holdings in Cooper Companies by 147.4% during the first quarter. HM Payson & Co. now owns 893 shares of the medical device company’s stock worth $75,000 after purchasing an additional 532 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Mizuho dropped their target price on shares of Cooper Companies from $105.00 to $90.00 and set an “outperform” rating for the company in a report on Wednesday. Piper Sandler reaffirmed an “overweight” rating and issued a $105.00 target price (down from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. Robert W. Baird dropped their target price on shares of Cooper Companies from $107.00 to $97.00 and set an “outperform” rating for the company in a report on Friday, May 30th. UBS Group raised shares of Cooper Companies to a “buy” rating in a research note on Tuesday, June 17th. Finally, Wall Street Zen cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Saturday, July 12th. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and an average price target of $97.20.

Cooper Companies Trading Down 0.5%

Shares of COO traded down $0.34 during mid-day trading on Friday, reaching $72.93. The company had a trading volume of 164,723 shares, compared to its average volume of 1,758,074. The stock has a market cap of $14.58 billion, a price-to-earnings ratio of 35.34, a price-to-earnings-growth ratio of 1.77 and a beta of 0.99. The firm has a fifty day simple moving average of $74.23 and a 200-day simple moving average of $82.18. The Cooper Companies, Inc. has a fifty-two week low of $65.00 and a fifty-two week high of $112.38. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.03. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. Cooper Companies’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the business earned $0.85 EPS. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.